Discovery of human macrophage migration inhibitory factor (MIF)-CD74 antagonists via virtual screening.

Macrophage migration inhibitory factor (MIF) is a cytokine that is involved in the regulation of inflammation as well as cell proliferation and differentiation. Deactivation of MIF by antibodies or inhibition of MIF binding to its receptor, CD74, attenuates tumor growth and angiogenesis. To discover small-molecule inhibitors of MIF's biological activity, virtual screening was performed by docking 2.1 million compounds into the MIF tautomerase active site. After visual inspection of 1200 top-ranked MIF-ligand complexes, 26 possible inhibitors were selected and purchased and 23 of them were assayed. The in vitro binding assay for MIF with CD74 revealed that 11 of the compounds have inhibitory activity in the micromolar regime, including four compounds with IC(50) values below 5 microM. Inhibition of MIF tautomerase activity was also established for many of the compounds with IC(50) values as low as 0.5 microM; Michaelis-Menten analysis was performed for two cases and confirmed the competitive inhibition.

[1]  William L Jorgensen,et al.  Optimization of pyrimidinyl- and triazinyl-amines as non-nucleoside inhibitors of HIV-1 reverse transcriptase. , 2006, Bioorganic & medicinal chemistry letters.

[2]  J. Bernhagen,et al.  Crystal structure at 2.6-A resolution of human macrophage migration inhibitory factor. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[3]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .

[4]  J. Bernhagen,et al.  Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF). , 1994, Biochemistry.

[5]  S. Yamamoto,et al.  Coumarin and chromen-4-one analogues as tautomerase inhibitors of macrophage migration inhibitory factor: discovery and X-ray crystallography. , 2001, Journal of medicinal chemistry.

[6]  E. Morand,et al.  Activation of synovial cell p38 MAP kinase by macrophage migration inhibitory factor. , 2004, The Journal of rheumatology.

[7]  M. Orita,et al.  Macrophage migration inhibitory factor and the discovery of tautomerase inhibitors. , 2002, Current pharmaceutical design.

[8]  Peter Björk,et al.  The macrophage migration inhibitory factor MIF is a phenylpyruvate tautomerase , 1997, FEBS letters.

[9]  S. Todo,et al.  An antibody for macrophage migration inhibitory factor suppresses tumour growth and inhibits tumour-associated angiogenesis. , 2000, Cytokine.

[10]  Tina Peng,et al.  Sustained Mitogen-activated Protein Kinase (MAPK) and Cytoplasmic Phospholipase A2 Activation by Macrophage Migration Inhibitory Factor (MIF) , 1999, The Journal of Biological Chemistry.

[11]  A. Chait,et al.  Oxidized LDL stimulates mitogen-activated protein kinases in smooth muscle cells and macrophages. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[12]  M. González-Gay,et al.  Evidence of association of macrophage migration inhibitory factor gene polymorphisms with systemic lupus erythematosus , 2006, Genes and Immunity.

[13]  J. Bernhagen,et al.  MIF as a glucocorticoid-induced modulator of cytokine production , 1995, Nature.

[14]  K. Iczkowski,et al.  Inhibition of Macrophage Migration Inhibitory Factor or Its Receptor (CD74) Attenuates Growth and Invasion of DU-145 Prostate Cancer Cells1 , 2006, The Journal of Immunology.

[15]  R. Bucala,et al.  Macrophage migration inhibitory factor , 2003, Critical care medicine.

[16]  T. Hagemann,et al.  Ovarian cancer cell–derived migration inhibitory factor enhances tumor growth, progression, and angiogenesis , 2007, Molecular Cancer Therapeutics.

[17]  Y. Al-Abed,et al.  Critical modifications of the ISO-1 scaffold improve its potent inhibition of macrophage migration inhibitory factor (MIF) tautomerase activity. , 2006, Bioorganic & medicinal chemistry letters.

[18]  E Lolis,et al.  Pro-1 of macrophage migration inhibitory factor functions as a catalytic base in the phenylpyruvate tautomerase activity. , 1999, Biochemistry.

[19]  Matthew P. Repasky,et al.  Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. , 2006, Journal of medicinal chemistry.

[20]  J. Bernhagen,et al.  MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis , 2006, Nature Reviews Drug Discovery.

[21]  Elias Lolis,et al.  The Tautomerase Active Site of Macrophage Migration Inhibitory Factor Is a Potential Target for Discovery of Novel Anti-inflammatory Agents* , 2002, The Journal of Biological Chemistry.

[22]  C. P. Whitman,et al.  Mechanism of the phenylpyruvate tautomerase activity of macrophage migration inhibitory factor: properties of the P1G, P1A, Y95F, and N97A mutants. , 2000, Biochemistry.

[23]  John David,et al.  Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: Regulatory role in the innate immune response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[24]  R. Bucala,et al.  An Essential Role for Macrophage Migration Inhibitory Factor (MIF) in Angiogenesis and the Growth of a Murine Lymphoma , 1999, Molecular medicine.

[25]  R. Bucala,et al.  Inhibition of macrophage migration inhibitory factor (MIF) tautomerase activity by dopachrome analogs. , 1999, Bioorganic & medicinal chemistry letters.

[26]  L. Leng,et al.  CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. , 2006, Immunity.

[27]  L. Leng,et al.  MIF Signal Transduction Initiated by Binding to CD74 , 2003, The Journal of experimental medicine.

[28]  R. Bucala,et al.  Biochemical and mutational investigations of the enzymatic activity of macrophage migration inhibitory factor. , 1997, Biochemistry.

[29]  R. Bucala,et al.  The Immunoregulatory Mediator Macrophage Migration Inhibitory Factor (MIF) Catalyzes a Tautomerization Reaction , 1996, Molecular medicine.

[30]  M. Swope,et al.  Macrophage migration inhibitory factor: cytokine, hormone, or enzyme? , 1999, Reviews of physiology, biochemistry and pharmacology.

[31]  Annette Lee,et al.  Macrophage migration inhibitory factor (MIF) gene polymorphisms are associated with increased prostate cancer incidence , 2007, Genes and Immunity.

[32]  W. L. Jorgensen,et al.  Development and Testing of the OPLS All-Atom Force Field on Conformational Energetics and Properties of Organic Liquids , 1996 .

[33]  R. Bucala,et al.  Inhibition of MIF bioactivity by rational design of pharmacological inhibitors of MIF tautomerase activity. , 2002, Journal of medicinal chemistry.

[34]  Matthew P. Repasky,et al.  Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. , 2004, Journal of medicinal chemistry.

[35]  Michael Bacher,et al.  ISO-1 Binding to the Tautomerase Active Site of MIF Inhibits Its Pro-inflammatory Activity and Increases Survival in Severe Sepsis* , 2005, Journal of Biological Chemistry.

[36]  J. Proudfoot,et al.  The evolution of synthetic oral drug properties. , 2005, Bioorganic & medicinal chemistry letters.

[37]  M. Fitzgerald,et al.  Characterization of the role of the amino-terminal proline in the enzymatic activity catalyzed by macrophage migration inhibitory factor. , 1998, Biochemistry.

[38]  W. Johnson,et al.  Crystal structure of macrophage migration inhibitory factor complexed with (E)-2-fluoro-p-hydroxycinnamate at 1.8 A resolution: implications for enzymatic catalysis and inhibition. , 1999, Biochemistry.

[39]  Peter D. Senter,et al.  Inhibition of macrophage migration inhibitory factor (MIF) tautomerase and biological activities by acetaminophen metabolites , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[40]  Brian K. Shoichet,et al.  ZINC - A Free Database of Commercially Available Compounds for Virtual Screening , 2005, J. Chem. Inf. Model..

[41]  R. Bucala,et al.  Regulation of macrophage migration inhibitory factor by endogenous glucocorticoids in rat adjuvant-induced arthritis. , 2000, Arthritis and rheumatism.

[42]  R. Bucala,et al.  Macrophage migration inhibitory factor: a critical component of autoimmune inflammatory diseases. , 2005, Drug news & perspectives.